Two-way Interaction Between Alisporivir and EDP239
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of Part 1 is to inform dose selection for use of alisporivir and EDP239 in
combination and obtain initial safety data for co-administration of alisporivir and EDP239 to
support future treatment studies in patients. The purpose of Part 2 is to inform the
drug-drug interaction potential of EDP239 more broadly and possibly facilitate the
interpretation of lower than expected alisporivir concentrations in Part 1, if observed.